Chemical SOP
Microbiology SOP
Warehouse SOP
Manufacturing SOP
Information technology SOP

Category Quality Risk Assessment

Risk Assessment of QMS Not Effective

Risk Assessment of QMS Not Effective

Risk Assessment of QMS Not Effective, an effective Quality Management System (QMS) forms the foundation of consistent product quality, regulatory compliance, and patient safety in pharmaceutical manufacturing and other regulated industries. The QMS integrates policies, procedures, processes, resources, and responsibilities…

Risk Assessment for Visual Inspection not Performed

Risk Assessment for Visual Inspection not Performed

1️⃣ Hazard Description Visual inspection is a critical step for detecting: Failure to perform visual inspection can result in defective or non-compliant products reaching patients. 2️⃣ Potential Causes 3️⃣ Potential Consequences 4️⃣ Risk Evaluation Matrix Aspect Assessment Severity High (potential…

Risk Assessment for Technology Transfer not Performed

Risk Assessment for Technology Transfer not Performed

Technology transfer is the formal process by which product and process knowledge developed during research and development is transferred to commercial manufacturing. It encompasses the transfer of manufacturing processes, analytical testing methods, in-process controls, cleaning procedures, and all relevant documentation…

Risk Assessment for Media Fill not Performed

1. What is Media Fill? Media fill (Process Simulation): Regulatory Expectation: Frequency: 2. Hazard Identification Hazard: Failure to perform or complete required media fill studies. Potential Causes: 3. Potential Impacts / Consequences Impact Area Description Product Quality Undetected contamination risk—no…

Risk Assessment for Flow Property of Granules

Risk Assessment for Flow Property of Granules

Risk Assessment for Flow Property of Granules in Pharmaceutical Manufacturing Introduction In solid oral dosage form manufacturing, particularly in tablet and capsule production, the flow properties of granules are a critical quality attribute. Granules must possess adequate and consistent flowability…

Risk Assessment for Culture Issues in Pharma

Risk Assessment for Culture Issues in Pharma

Risk Assessment for Culture Issues in the Pharmaceutical Industry Introduction In the pharmaceutical industry, organizational culture is a critical factor influencing GMP compliance, data integrity, product quality, and ultimately, patient safety. Culture encompasses the values, behaviors, attitudes, and decision-making patterns…

Risk Assessment for Analysis not performed for Excipients

Risk Assessment for Analysis not performed for Excipients

Introduction In pharmaceutical manufacturing, excipients play a crucial role in ensuring the quality, stability, and performance of drug products. While they are considered “inactive” ingredients, their impact on the safety, efficacy, and manufacturability of formulations is significant. Regulatory authorities require…

error: Content is protected !!